FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Zhang Junge

2. Date of Event Requiring Statement (MM/DD/YYYY)
9/27/2019 

3. Issuer Name and Ticker or Trading Symbol

Ocugen, Inc. [OCGN]

(Last)        (First)        (Middle)

C/O OCUGEN, INC. 5 GREAT VALLEY PARKWAY,, SUITE 160

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)

(Street)

MALVERN, PA 19355      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 212863 I By Trust 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants (Right to Buy) 9/27/2019 1/10/2025 Common Stock 143820 $2.77 I By Trust 
Warrants (Right to Buy) 9/27/2019 6/12/2027 Common Stock 1653 $7.56 I By Trust 

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Zhang Junge
C/O OCUGEN, INC. 5 GREAT VALLEY PARKWAY,
SUITE 160
MALVERN, PA 19355
X



Signatures
/s/ Junge Zhang by [Kelly Beck] his attorney-in-fact10/2/2019
**Signature of Reporting PersonDate

Histogenics (NASDAQ:HSGX)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Histogenics 차트를 더 보려면 여기를 클릭.
Histogenics (NASDAQ:HSGX)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Histogenics 차트를 더 보려면 여기를 클릭.